SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer inches up on partnering with 'Doctors For You' to create 400 oxygen bed capacity at Delhi

08 Jun 2021 Evaluate

Pfizer is currently trading at Rs. 5199.15, up by 2.35 points or 0.05% from its previous closing of Rs. 5196.80 on the BSE.

The scrip opened at Rs. 5216.95 and has touched a high and low of Rs. 5216.95 and Rs. 5182.30 respectively. So far 697 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 5875.00 on 10-Nov-2020 and a 52 week low of Rs. 3958.80 on 01-Jul-2020.

Last one week high and low of the scrip stood at Rs. 5233.35 and Rs. 5124.00 respectively. The current market cap of the company is Rs. 23812.38 crore.

The promoters holding in the company stood at 63.92%, while Institutions and Non-Institutions held 16.52% and 19.55% respectively.

Pfizer has partnered with the non-governmental organization, Doctors For You, to help create 400 oxygen bed capacity at Delhi's Yamuna COVID care center. With a grant of Rs 4.5 crore from Pfizer, Doctors For You has procured and deployed 400 high-quality beds with oxygen support and other medically necessary equipment and services of medical and paramedical staff services to maintain the operations at the facility. 10 percent of these beds have been set up to specifically meet the requirements of COVID-19 pediatric patients.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

4896.15 46.35 (0.96%)
15-Apr-2026 09:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1671.00
Dr. Reddys Lab 1213.85
Cipla 1224.95
Zydus Lifesciences 929.00
Lupin 2335.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×